Approved Immunotherapy, Keytruda, Shrinks, Eliminates Rare, Aggressive Melanoma, Clinical Trial Finds

FRIDAY, Jan. 30, 2026 — An already-approved immunotherapy drug can dramatically shrink — or even eliminate — tumors associated with a rare and aggressive form of melanoma, a new clinical trial has found.
About 71% of desmoplastic...